Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. Issue 2 (December 2015) - Ruella, Marco; Barrett, David; Kenderian, Saad; Shestova, Olga; Hofmann, Ted; Scholler, John; Lacey, Simon; Melenhorst, Jan; Nazimuddin, Farzana; Perazzelli, Jessica; Christian, David; Hunter, Christopher; et al.